BioWorld MedTech

Feb. 20, 2013

SEMDA 2013: Leahey: med-tech firms' voices still matter despite difficulties

ATLANTA — Some would say that in recent years the landscape for med-tech has been littered with difficulties and challenges often resulting in many devicemakers feeling as if their voice has been diminished. Read More

NewCo on the Go: ForeCYTE test like Pap smear for breast cancer

Report from Europe: Dune Medical in compliance for next-gen MarginProbe

Washington roundup: Neiman Institute offers rubric for evaluating repeat imaging

Financings roundup: PolyActiva raises more than $9M in Series B funding round

Agreements/contracts: Laser Spine partners with Marodyne for LivMD device

Deals roundup: Liaison sees opportunities in HIT via Ignis acquisition

HIT roundup: EMH Healthcare goes live on Capsule's MVP

Med-Tech Notes

People in the News

Product Briefs

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for Dec. 19, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 19, 2025.

Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

HIV research is close to a cure but far from ending the pandemic

BioWorld

Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...

Apollo’s APL-4098 shows potent antileukemic effects

BioWorld Science

Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.

Illustration of brain with electrical activity background

ABS-1230 controls seizures in KCNT1-driven severe epilepsy

BioWorld Science

Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...